Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family
- 21 June 2005
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 5 (12) , 1731-1740
- https://doi.org/10.1016/j.intimp.2005.05.010
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Therapeutic efficacy of humanized recombinant anti–interleukin‐6 receptor antibody in children with systemic‐onset juvenile idiopathic arthritisArthritis & Rheumatism, 2005
- Treatment of rheumatoid arthritis with humanized anti–interleukin‐6 receptor antibody: A multicenter, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2004
- A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease☆Gastroenterology, 2004
- Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapyBlood, 2000
- New Xenograft Model of Multiple Myeloma and Efficacy of a Humanized Antibody Against Human Interleukin-6 ReceptorBlood, 1997
- Recombinant soluble human interleukin‐6 receptorEuropean Journal of Biochemistry, 1993
- Interleukin-6 in Biology and MedicinePublished by Elsevier ,1993
- Anti‐human interleukin‐6 receptor antibody inhibits human myeloma growth in vivoEuropean Journal of Immunology, 1992
- Molecular cloning and expression of an IL-6 signal transducer, gp130Cell, 1990
- Purification and Characterization of Soluble Human IL-6 Receptor Expressed in CHO CellsThe Journal of Biochemistry, 1990